Geneva, July 7 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000062024) titled 'An in silico study comparing dose distributions between carbon ion radiotherapy and stereotactic body radiotherapy for hepatocellular carcinoma' on June 24.

Study Type: Others,meta-analysis etc

Study Design: Not selected Not selected

Primary Sponsor: National Institutes for Quantum Science and Technology (QST)

Condition: hepatocellular carcinoma

Recruitment Status: Recruiting

Phase: Not selected

Date of First Enrollment: 2026/06/24

Target Sample Size: 40

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070973

Published by H...